Post-stroke depression: the case for augmented, individually tailored cognitive behavioural therapy

Clinical Psychology & Psychotherapy
Niall M BroomfieldDavid C Gillespie

Abstract

In this review, we begin by considering why post-stroke depression (PSD) is so prevalent. We then examine the current evidence base to support cognitive behavioural therapy (CBT) as a treatment approach for the condition. While there is limited evidence currently, we demonstrate that much remains to be established with regard to PSD and the efficacy of CBT. We argue there is every reason to believe CBT should be an effective treatment, but that clinicians must augment and individually tailor this approach to ensure effectiveness. We set out our rationale for a novel augmented, individually tailored CBT protocol, and describe five key components that we believe once incorporated, and tested using randomized controlled methods, should enhance treatment outcome of PSD.

References

Sep 1, 1991·Memory & Cognition·P S Seibert, H C Ellis
Jun 1, 1990·Archives of General Psychiatry·J K WingN Sartorius
Dec 1, 1988·Journal of Personality and Social Psychology·D Derryberry, M K Rothbart
Nov 1, 1983·Comprehensive Psychiatry·R G RobinsonT R Price
Jun 1, 1983·Acta Psychiatrica Scandinavica·A S Zigmond, R P Snaith
Feb 1, 1994·Journal of Neurology, Neurosurgery, and Psychiatry·T K TatemichiE Bagiella
Sep 1, 1996·Nursing Research·C T Beck
Jan 1, 1995·International Psychogeriatrics·R W Grant, D A Casey
Jan 1, 1997·International Journal of Psychiatry in Medicine·S ParadisoR G Robinson
Sep 10, 1998·Journal of Personality and Social Psychology·C G DavisJ Larson
Mar 13, 1999·The Journal of Clinical Psychiatry·M S BauerB J Powell
Mar 13, 1999·The Journal of Clinical Psychiatry·L L CarpenterL H Price
Jul 14, 1999·Behaviour Research and Therapy·J D Teasdale
Oct 26, 1999·The British Journal of Psychiatry : the Journal of Mental Science·A T BeekmanM J Prince
Dec 11, 1999·Journal of Geriatric Psychiatry and Neurology·M S NoblerH A Sackeim
Jan 7, 2000·Journal of Clinical Nursing·A M ChangR Dhillon
May 2, 2000·The British Journal of Clinical Psychology·I I Kneebone, E Dunmore
Mar 10, 2001·Stroke; a Journal of Cerebral Circulation·A HouseA Vail
Jun 2, 2001·Stroke; a Journal of Cerebral Circulation·E S LawrenceC D Wolfe
Jun 26, 2001·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·T PohjasvaaraT Erkinjuntti
Jul 7, 2001·Stroke; a Journal of Cerebral Circulation·S C LewisM Sharpe
Oct 25, 2002·The British Journal of Clinical Psychology·Catherine R NichollShirley Thomas
Jan 4, 2003·Stroke; a Journal of Cerebral Circulation·N B Lincoln, T Flannaghan
Oct 1, 2003·Journal of Consulting and Clinical Psychology·Brian L BurkeMarisa Menchola
Apr 24, 2004·The Cochrane Database of Systematic Reviews·C S AndersonA O House
Jul 22, 2004·The Cochrane Database of Systematic Reviews·M L HackettA O House
Feb 9, 2005·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Benjamin T MastPeter A Lichtenberg
Feb 11, 2005·Behaviour Research and Therapy·Jan Mohlman, Jack M Gorman
Mar 19, 2005·Brain : a Journal of Neurology·Dana SamsonGlyn W Humphreys
May 10, 2005·Stroke; a Journal of Cerebral Circulation·Maree L HackettCraig S Anderson
Aug 9, 2005·Archives of Physical Medicine and Rehabilitation·Lana A TierskyJohn Deluca
Feb 17, 2006·The British Journal of Clinical Psychology·Shirley A Thomas, Nadina B Lincoln
Sep 2, 2006·The American Journal of Psychiatry·Martin PinquartJeffrey M Lyness
Nov 11, 2006·International Journal of Geriatric Psychiatry·Niall M BroomfieldSusan M B Cross
Feb 17, 2007·Stroke; a Journal of Cerebral Circulation·Caroline L WatkinsMichael J Leathley
Apr 5, 2007·Psychological Medicine·Fiona A McDougallUNKNOWN Medical Research Council Cognitive Function and Ageing Study
Apr 25, 2007·Disability and Rehabilitation·Adina Hartman-MaeirNoomi Katz

❮ Previous
Next ❯

Citations

Sep 16, 2011·Neuropsychological Rehabilitation·Gavin H TaylorNiall M Broomfield
Jul 31, 2013·Neuropsychological Rehabilitation·Ian I Kneebone, Fiona W Jeffries
Dec 19, 2015·Disability and Rehabilitation·Ian I Kneebone
Jan 31, 2012·Neurologic Clinics·Nadejda AlekseevaAlireza Minagar
Jan 5, 2016·Neuropsychological Rehabilitation·Breda CullenJonathan J Evans
Mar 7, 2015·The Tohoku Journal of Experimental Medicine·Yeongcheol Eum, Jongeun Yim
Sep 19, 2015·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Xiaolu QianShuang Zhou
Dec 25, 2012·Archives of Physical Medicine and Rehabilitation·Wai Kwong TangKa-Sing Wong
Apr 26, 2011·Journal of Affective Disorders·Marcus WeilandGabriela Stoppe
Aug 23, 2016·Expert Review of Neurotherapeutics·Satu BaylanTerry Quinn
Nov 17, 2016·Archives of Physical Medicine and Rehabilitation·Joyce A KootkerAlexander C H Geurts
Aug 22, 2018·The British Journal of Clinical Psychology·Fionnuala C MurphyTom Manly
Feb 14, 2018·Stroke; a Journal of Cerebral Circulation·Ho-Yan Yvonne ChunAlan J Carson
Mar 15, 2019·Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology·Birgit MazurekPetra Brueggemann
Apr 7, 2016·Journal of the International Neuropsychological Society : JINS·Matthew J HollocksHugh S Markus
Sep 17, 2019·Health Technology Assessment : HTA·Shirley A ThomasGogem Topcu
Nov 23, 2016·Neuropsychological Rehabilitation·Melanie GallagherThomas M McMillan
Dec 20, 2019·Neuropsychological Rehabilitation·F E SmithA De Simoni
Jan 8, 2021·BMC Complementary Medicine and Therapies·Caitlin Kar Pui ChanRainbow Tin Hung Ho
Feb 10, 2020·The Medical Clinics of North America·Leroy R LindsayMichael W O'Dell

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.